Low doses interferon-alpha in the treatment of high-risk cutaneous melanoma. Melanoma Cooperative Group.
Ascierto
P A
PA
National Tumor Institute Fondazione G. Pascale Naples, Italy.
Palmieri
G
G
Strazzullo
M
M
Daponte
A
A
Botti
G
G
Satriano
S M
SM
Motti
M L
ML
Mozzillo
N
N
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018572:Disease-Free Survival; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008207:Lymphatic Metastasis; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000556:secondary; D012307:Risk Factors; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology
D000970:Antineoplastic Agents; D016898:Interferon-alpha